Whole Biome Collaborating with Mayo Clinic

Whole Biome, Inc. is co-developing microbiome targeted diagnostic testing with the Mayo Clinic Center for Individualized Medicine, beginning in Women’s Health, with a focus on preterm labor. Learn more

AO Biome Wins Dermatology Shark Tank Contest

AOBiome, the leading skin microbiome company, has been awarded $15K in the Dermatology Entrepreneurship Shark Tank contest for their work in the skin microbiome. Learn more

Second Genome Secures $46.2 Million in Series B Financing

Second Genome, Inc., a privately-held biopharmaceutical company developing novel medicines through innovative microbiome science, today announced that it has closed an oversubscribed Series B investment round with $42.6 million in financing. The round was co-led by Pfizer Venture Investments and Roche Venture Fund, and brings the combined total investment in the company to $59 million. Learn more